CHU de Montpellier — Clinical Trial Site

10 Registered trials

7 Currently recruiting

Organisation

CHU de Montpellier

Location

Montpellier Cedex 05, France

Identifier

ORL-000005974

Address

371 avenue du doyen Gaston Giraud, 34295, France

Departments

Hepato-gastroenterologie et transplantation
Onco-Hématologie pédiatrique
Oncology for pediatrics
Pediatric oncology department
Pediatrics
Psychiatrie
Service d'Hépatologie gastroentérologie et nutrition pédiatrique
Service des Maladies Respiratoires
Service des Maladies Respiratoires - Unité d'oncologie thoracique
UAM Hématologie et Oncologie Pédiatrique

Clinical trials at this site (10)

Search interface

IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Relapsed Acute Lymphoblastic Leukemia (ALL) 5
CAALL-F01: a French protocol for the treatment of acute lymphoblastic leukemia (ALL) in children and adolescents Pending

2024-514243-29-01 This is a prospective, French, multicenter, open-label, 5
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis Recruiting

2024-511458-32-00 Ulcerative colitis 5 2025-06-15
A Study to evaluate the long-term safety and tolerability of tozorakimab in patients with chronic obstructive pulmonary disease (COPD) and a… Recruiting

2025-523690-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2026-05-04
INTER-EWING-1: International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma – Trial 1 Recruiting

2024-511989-36-00 Ewing Sarcoma 5 2025-09-24
Treatment with acetylcholine esterase inhibitors in anorexia nervosa : a multicenter double-blind randomised controlled trial versus placebo Recruiting

2024-511681-37-00 Anorexia nervosa 4 2025-07-02
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s … Recruiting

2024-517794-24-00 crohn disease 4 2024-10-24
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
A clinical study to test the safety and efficacy of GB1211 in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSC… Ended

2024-514419-93-00 Study to investigate the safety and efficacy of GB1211 9 2022-05-19